{
  "main_header": {
    "sid": 10039897,
    "name": "Nephrocare Healt",
    "stock_name": "Nephrocare Healt",
    "full_name": "Nephrocare Health Services Ltd",
    "name_url": "stocks-analysis/nephrocare-healt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "513.00",
    "chg": -7.05,
    "chgp": "-1.36%",
    "dir": -1,
    "prev_price": "520.05",
    "mcapval": "5,221.00 Cr",
    "mcap": "",
    "scripcode": 544647,
    "symbol": "NEPHROPLUS",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE428V01029",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.12 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/nephrocare-healt-10039897-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039897",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/nephrocare-health-services-10039897"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Jan-2026",
      "details": "Pursuant to Regulation 30 of the Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 11th February 2026 at 16:00 (Indian Standard Time) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2025. A copy of the invitation is attached for your information.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31St December 2025.",
      "datetime": "30-Jan-2026",
      "details": "Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "27-Jan-2026",
      "details": "Pursuant to Reg 30 of SEBI LODR Regulations 2015 we hereby inform that Nephrocare Health Services Philippines Inc the Step down subsidiary of the Company has acquired a Dialysis centre and has executed Asset Transfer Agreement and Memorandum of Agreement as per the disclosure annexed herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News